In vitro-derived genetically altered human neutrophil precursor cells and methods for administering the same
Patent Number: 6146623
Date of First Priority Issue: Monday March 23rd, 1992
Date Issued: Tuesday November 14th, 2000
Assignee: Nexell Therapeutics Inc. (Irvine, CA)
Inventors: Bender, James G. (Lindenhurst, IL); Maples, Phillip B. (Waukegan, IL); Smith, Stephen (Arlington Heights, IL); Unverzagt, Kristen L. (Palatine, IL); Van Epps, Dennis E. (Cary, IL)
From Class: Extraction/Preservation
Comments: No comments
This patent covers genetic transfection of stem cells that give rise to neutrophils. Transfection of this cell population may be performed to enhance their ability to proliferate, or may be performed to endow them with increased antibacterial activities.
View this patent on the USPTO website.
Added to StemCellPatents.com on Monday October 16th, 2006
Social & Bookmarking:
Add Comment
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.